CardioLync

Company Overview

Snapshot

Founded in January 2016 by Jeremy Kagan and Jacob Levy, CardioLync operated with 1–10 employees. The company ceased operations in November 2022, after having been selected to present at the 2017 New England Venture Summit.

Business overview

CardioLync developed a platform designed for interpreting cardiovascular studies, generating reports, and managing patients' cardiac histories. Its technology provided an easy-to-use interface to facilitate the seamless and secure movement of clinical data, enabling clinicians to interpret diagnostic studies remotely and patients to access their imaging history from anywhere. The company operated within the Health Tech & Life Sciences sector, focusing on digital healthcare, clinical workflow, and patient engagement, serving healthcare providers and patients.

Strategic signal

In August 2021, CardioLync joined NVIDIA Inception, a program designed to nurture cutting-edge startups. This participation signaled the company's focus on leveraging advanced AI and GPU technologies to enhance its platform for cardiovascular data interpretation and patient management, indicating a strategic direction towards technological innovation and potential scalability within the health tech sector.

Company Intelligence Q&A

What is CardioLync's operational status?

CardioLync is currently non-active, having ceased operations in November 2022.

When was CardioLync founded and by whom?

CardioLync was founded in January 2016 by Jeremy Kagan and Jacob Levy.

What significant industry program did CardioLync join?

In August 2021, CardioLync joined NVIDIA Inception, a program supporting cutting-edge startups.

What was a key recognition for CardioLync in its early stages?

CardioLync was selected to present at the 2017 New England Venture Summit in December 2017.

Who joined CardioLync's Scientific Advisory Board in February 2022?

Dr. Diego Gicovate, PhD, joined CardioLync's Scientific Advisory Board in February 2022.